Sentence examples for present study evaluated the safety from inspiring English sources
The present study evaluated the safety and efficacy of the Vela laser for en bloc resection of papillary bladder tumors.
The present study evaluated the safety and tolerability of an all-oral combination of everolimus and capecitabine for metastatic breast cancer (MBC).
The present study evaluated the safety and efficacy of an intragastric dual balloon as an adjunct to diet and exercise in obese patients compared with diet and exercise alone.
The present study evaluated the safety of autologous BMDMC administration through bronchoscopy in patients with silicosis over a period of 360 days.
The present study evaluates the safety and efficacy of the Adipose Graft Transposition Procedure (AGTP) as a biological regenerative innovation for patients with a chronic myocardial scar.
The present study evaluated the pharmacokinetic profile, safety, and immunogenicity of fremanezumab doses tested in the phase 2 and 3 trials (225mg, 675mg and 900mg) following single administration in Japanese (n=32) and Caucasian (n=32) healthy subjects.
The present study evaluated the efficacy and safety of Zalviso® sublingual sufentanil tablet system (SSTS) in comparison to our standard of care for postoperative pain management, a multimodal analgesic approach with cFNB, in a population of TKA patients managed according to fast track rehabilitation principles.
The present study evaluated the efficacy and safety of a new bronchoscopic technique using intratumoral injection of tranexamic acid (IIT) for control of bleeding during forceps biopsy in patients with endobronchial tumors with a high risk of bleeding.
The present phase I study evaluated the safety, pharmacokinetics, and efficacy of buparlisib with capecitabine in patients with metastatic breast cancer.
The present study evaluates the clinical efficacy and safety of an intervention programme based on this guidance aimed to reduce physical restraints and minimise centre variations.
The present study evaluated further the safety, reactogenicity and immunogenicity of a fourth consecutive (booster) dose of PHiD-CV.
